The Chinese Diabetes Society's 2024 guideline (published Jan 2025) is a 20-chapter update covering diagnosis, three-tier prevention, glucose-lowering drugs, weight management, complications, and care for children, adolescents, and type 1 diabetes.
“China Diabetes Guideline 2024: A Patient Guide” is part of iMedCompanion’s plain-language library for international patients travelling to China for care. It explains what usually happens, what to prepare, and where to find related specialists and hospitals.
No. It explains what usually happens so you can ask better questions; decisions are made with your own specialist.
The guides are published in English; interpretation and translation are arranged as a separate service.
Each guide links to related specialists and hospitals, or you can send an enquiry and a medical advisor will match you.
For people with diabetes and high blood pressure, the 2025 Chinese guideline targets below 130/80 mmHg and favors SGLT2 inhibitors and…
China's 2024 guideline stresses lifelong co-management of gestational diabetes in mother and child to reduce pregnancy risks and future…
How diabetes is monitored and managed over years rather than weeks, and what an international patient should arrange before leaving China.
